沙美特罗替卡松气雾剂联合粉尘螨滴剂舌下免疫治疗尘螨过敏性哮喘的临床效果

doi:10.3969/j.issn.1007-3205.2021.10.013

河北医科大学学报 ›› 2021, Vol. 42 ›› Issue (10): 1180-1184.doi: 10.3969/j.issn.1007-3205.2021.10.013

沙美特罗替卡松气雾剂联合粉尘螨滴剂舌下免疫治疗尘螨过敏性哮喘的临床效果

上海市第六人民医院东院儿科，上海 200000

出版日期:2021-10-25 发布日期:2021-10-28
作者简介:郑芳（1980-），女，河南郑州人，上海市第六人民医院东院主治医师，医学学士，从事儿童哮喘和呼吸道感染临床研究。
基金资助:
上海市第六人民医院东院院级科研基金项目（院人才2016021）

Clinical effect of salmeterol xinafoate and fluticasone propionate aerosol combined with sublingual immunotherapy with dust mite drops on dust mite allergic asthma

Department of Pediatrics, East Branch of the Sixth People′s Hospital of Shanghai City, Shanghai 200000, China

Online:2021-10-25 Published:2021-10-28

摘要/Abstract

摘要： 目的观察总结尘螨过敏性哮喘患儿接受沙美特罗替卡松气雾剂联合舌下含服粉尘螨滴剂治疗的临床效果。
方法选择我院门诊收治的尘螨过敏性哮喘患儿85例为研究对象，依照随机数字表法分为2组，分别接受沙美特罗替卡松气雾剂治疗（对照组42例）与沙美特罗替卡松气雾剂联合粉尘螨滴剂舌下免疫治疗（观察组43例），评价2组患儿治疗效果及治疗前后临床指标变化情况，并统计分析2组患儿治疗期间不良反应发生情况。
结果治疗后总有效率比较，观察组总有效率为93.02%（40/43）明显高于对照组的76.19%（32/42），差异有统计学意义（P＜0.05）；观察组治疗后血清尘螨人特异性免疫球蛋白（specific immunoglobulin,SIg）G4、血清白细胞介素（interleukin，IL）12指标改善均优于对照组，差异有统计学意义（P＜0.05）；观察组治疗后哮喘日间症状评分、夜间症状评分均低于对照组，比较差异有统计学意义（P＜0.05）；治疗期间2组患儿均存在轻微程度的咽喉疼痛，其中观察组4例（9.30%）、对照组3例（7.14%），差异无统计学意义（χ2=0.131，P=0.717）。
结论尘螨过敏性哮喘患儿行沙美特罗替卡松气雾剂联合粉尘螨滴剂舌下免疫治疗，对患儿气道炎症、免疫失衡等哮喘症状改善效果明显，具有较高的临床应用价值。

关键词: 哮喘, 氟替卡松-沙美特罗替合剂, 儿童

Abstract: Objective To observe and summarize the clinical effect of salmeterol xinafoate and fluticasone propionate aerosol combined with sublingual dust mite drops in children with dust mite allergic asthma.
Methods A total of 85 children with dust mite allergic asthma who were admitted to our hospital were selected and divided into 2 groups by random number table method. The control group received salmeterol xinafoate and fluticasone propionate aerosol(n=42) and the observation group received salmeterol xinafoate and fluticasone propionate aerosol combined with sublingual immunotherapy with dust mite drops(n=43). The therapeutic effects of the two groups and the changes in clinical indicators before and after treatment were summarized, and incidence of adverse reactions during treatment was analyzed in two groups.
Results After treatment, the total effective rate in the observation group was 93.02%(40/43), which was significantly higher than 76.19%(32/42) in the control group, and the difference was statistically significant(P＜0.05). After treatment, the improvement of serum dust mite specific immunoglobulin G(SIgG4) and serum interleukin(IL)-12 in the observation group was better than that in the control group, and the difference was statistically significant(P＜0.05). The daytime symptom score and nighttime symptom score of asthma in the observation group were lower than those in the control group after treatment, and the difference was statistically significant(P＜0.05). During the treatment period, there was mild throat pain in both groups, including 4 cases(9.30%) in the observation group and 3 cases(7.14%) in the control group, however, there was no statistically significant difference(χ2=0.131, P=0.717).
Conclusion Salmeterol xinafoate and fluticasone propionate aerosol combined with sublingual immunotherapy with dust mite drops for children with dust mite allergic asthma is effective in ameliorating the asthma symptoms of children such as airway inflammation and immune imbalance. Therefore, it has good application value in clinical practice.

Key words: sthma, salmeterol xinafoate and fluticasone propionate aerosol, child

郑芳, 卞相丽, 李妙晨, 吴志敏. 沙美特罗替卡松气雾剂联合粉尘螨滴剂舌下免疫治疗尘螨过敏性哮喘的临床效果[J]. 河北医科大学学报, 2021, 42(10): 1180-1184.

ZHENG Fang, BIAN Xiang-li, LI Miao-chen, WU Zhi-min. Clinical effect of salmeterol xinafoate and fluticasone propionate aerosol combined with sublingual immunotherapy with dust mite drops on dust mite allergic asthma[J]. Journal of Hebei Medical University, 2021, 42(10): 1180-1184.

[1]	李佳, 何霞. 血清Leptin、CCL26在反复喘息患儿中的变化及与哮喘预测指数的相关性 [J]. 河北医科大学学报, 2023, 44(8): 934-940.
[2]	李君, 叶方, 韩富光, 李波. 变应性鼻炎患者nFeNO、OPN、sIgE表达及对合并哮喘的辅助诊断价值 [J]. 河北医科大学学报, 2023, 44(6): 697-701.
[3]	田文朋, 徐炳磊, 吕秀敏. 西替利嗪辅助沙丁胺醇对支气管哮喘急性发作患儿气道重塑、PDCD5、S1P水平的影响[J]. 河北医科大学学报, 2022, 43(5): 574-577.
[4]	刘红红, 邢宁宁, 师丽敏, 李爱军. 支气管哮喘患者气道炎症与EOS的PI3K/Akt信号通路活化程度的关系研究[J]. 河北医科大学学报, 2021, 42(8): 881-885.
[5]	邵长宝, 王元桥, 马琳娟, 尹浩, 王建星. 经鼻雾化吸入布地奈德混悬液联合克拉霉素治疗慢性鼻-鼻窦炎鼻息肉伴支气管哮喘患者的临床研究[J]. 河北医科大学学报, 2021, 42(8): 930-934,949.
[6]	白磊鹏, 吕家兴, 王瑜, 孔庆柱, 金宇, 赵景新. 经皮穿针联合外固定架微创治疗大龄儿童肱骨近端骨折的效果分析[J]. 河北医科大学学报, 2021, 42(4): 420-424.
[7]	余〓洪. 丙卡特罗联合甲泼尼龙治疗支气管哮喘患者的效果分析[J]. 河北医科大学学报, 2019, 40(8): 946-949.
[8]	李小明. 支气管哮喘患者外周血CD4+T、CD8+T、Th17、IL17表达水平与肺功能的相关性研究[J]. 河北医科大学学报, 2018, 38(5): 504-507,513.
[9]	潘文森1，肖冉冉1，关继涛2，李爱民3，杨红申1. 阿托伐他汀对哮喘大鼠气道炎症、重塑及血清学相关炎症指标的影响[J]. 河北医科大学学报, 2017, 37(9): 1007-1010,1019.
[10]	施雄飞，邵成喜，杨秋宝，罗坤锋. 急诊应用布地奈德联合福莫特罗干粉剂治疗支气管哮喘的效果观察[J]. 河北医科大学学报, 2017, 37(8): 953-956.
[11]	李晓光1，安小军2，韩〓玮3，史翠红3，王建平4，刘艳清5. 利美达松对哮喘持续状态的临床疗效及对呼气流速峰的影响[J]. 河北医科大学学报, 2017, 37(5): 595-598.
[12]	李国华1，周希胜2，李亚芳（通讯作者）3. 抗炎症因子抗体局部雾化治疗支气管哮喘的实验研究[J]. 河北医科大学学报, 2016, 37(12): 1466-.
[13]	高洪芬. 240例哮喘患儿临床预后分析[J]. 河北医科大学学报, 2016, 37(11): 1337-1340.
[14]	韩雪娇;王亮;杨红申;侯宏伟;李亚妹;李香兰. 多西环素对哮喘大鼠血管内皮生长因子、基质金属蛋白酶9的作用及血管重塑的影响[J]. , 2015, 36(6): 638-638.
[15]	王亮;倪为波;杨红申. 盐酸多西环素对哮喘大鼠基质金属蛋白酶9/基质金属蛋白酶组织抑制剂1平衡的影响[J]. , 2015, 36(5): 505-505.

沙美特罗替卡松气雾剂联合粉尘螨滴剂舌下免疫治疗尘螨过敏性哮喘的临床效果

Clinical effect of salmeterol xinafoate and fluticasone propionate aerosol combined with sublingual immunotherapy with dust mite drops on dust mite allergic asthma

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价